Related Experiment Video
Updated: Jul 14, 2026
08:01
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
Using diffusion of innovations theory to guide diabetes management program development: an illustrative example.
Mirella De Civita1, Kaberi Dasgupta
1Division of Clinical Epidemiology, Department of Medicine, McGill University Health Centre, 687 Pine Avenue West, V Building, Montreal, Quebec, Canada H3A 1A1.
Journal of Public Health (Oxford, England)
|June 15, 2007
Summary
Implementing effective type 2 diabetes management programs requires addressing physician perceptions and organizational integration. A knowledge transfer plan is crucial for program adoption and long-term sustainability.
Area of Science:
- Health Services Research
- Diabetes Management
- Implementation Science
Background:
- Optimal type 2 diabetes management necessitates achieving glucose, blood pressure, and lipid targets.
- This requires lifestyle changes, medication adherence, and coordinated multidisciplinary services.
- Diffusion of Innovations Theory provides a framework for implementing new healthcare programs.
Purpose of the Study:
- To examine implementation factors of a diabetes management pilot program.
- To identify process factors enhancing adoption and sustainability of such programs.
Main Methods:
- Re-examination of previously reported implementation experiences of a diabetes management pilot program.
- Analysis focused on process factors influencing program adoption and sustainability.
Main Results:
- Physician participation was linked to perceived advantages, compatibility, and barriers.
- Program integration within the existing healthcare system influenced participation.
- Organizational features played a role in physician engagement.
Conclusions:
- System and team integration require partnerships among stakeholders including producers, government, industry, professionals, and patients.
- A knowledge transfer action plan is essential for guiding program development, implementation, and sustainability.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...